Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Janssen Biotech Inc patents

Recent patent applications related to Janssen Biotech Inc. Janssen Biotech Inc is listed as an Agent/Assignee. Note: Janssen Biotech Inc may have other listings under different names/spellings. We're not affiliated with Janssen Biotech Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "J" | Janssen Biotech Inc-related inventors




Date Janssen Biotech Inc patents (updated weekly) - BOOKMARK this page
08/17/17 new patent  Compositions and methods for phagocyte delivery of anti-staphylococcal agents
08/03/17Bispecific anti-tnf-alpha/il17a antibodies and anti-tnf-alpha antibodies and methods of their use
07/27/17Anti-ror1, antibodies, ror1 x cd3 bispecific antibodies, and methods of using the same
07/20/17Antibody fc mutants with ablated effector functions
06/29/17Differentiation of pluripotent stem cells
06/29/17Differentiation of pluripotent stem cells
06/29/17Defined media for expansion and maintenance of pluripotent stem cells
06/29/17Differentiation of human embryonic stem cells
06/22/17Combination therapies with anti-cd38 antibodies
06/08/17Treatment of retinal degeneration using progenitor cells
06/08/17Method of treating lupus by administering an anti-il-12 antibody
05/25/17Human oncostatin m antibodies and methods of use
05/04/17Antibodies specifically binding pd-1, tim-3 or pd-1 and tim-3 and their uses
05/04/17Subcutaneous formulations of anti-cd38 antibodies and their uses
05/04/17Subcutaneous formulations of anti-cd38 antibodies and their uses
04/20/17Combination therapies with anti-cd38 antibodies
04/13/17Bispecific egfr/c-met antibodies
03/30/17Agonistic antibodies specifically binding cd40 and methods of use
03/23/17Treatment of retinal degeneration using progenitor cells
03/23/17Peptide antagonist of ll-37
03/23/17Differentiation of human embryonic stem cells
03/09/17St2l antagonists and methods of use
03/02/17Toll-like receptor 3 antagonists
02/16/17Anti-il-23 antibodies, compositions, methods and uses
02/16/17Immune modulation and treatment of solid tumors with antibodies that specifically bind cd38
02/16/17Differentiation of human embryonic stem cells into pancreatic endocrine cells
02/09/17Anti-cd154 antibodies and methods of using them
01/12/17Anti-cd38 antibodies for treatment of light chain amyloidosis and other cd28-positive hematological malignancies
01/12/17Differentiation of human embryonic stem cells
12/29/16Immune modulation and treatment of solid tumors with antibodies that specifically bind cd38
12/22/16Combination therapies for heme malignancies with anti-cd38 antibodies and survivin inhibitors
12/01/16Cardiac tissue-derived cells
12/01/16Prostate specific membrane antigen (psma) bispecific binding agents and uses thereof
11/10/16Prostate specific membrane antigen binding fibronectin type iii domains
11/03/16Anti-il-12 antibody nucleic acids and methods
10/20/16Anti-phf-tau antibodies and their uses
10/06/16Protoxin-ii variants and methods of use
09/15/16Anti-tnf antibodies, compositions, methods and uses
09/08/16Protoxin-ii variants and methods of use
09/01/16Defined media for expansion and maintenance of pluripotent stem cells
08/25/16Cell encapsulation loading device
08/25/16Stabilized fibronectin domain compositions, methods and uses
08/18/16Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recombinant proteins
08/18/16Human anti-il-23 antibodies, compositions, methods and uses
08/04/16Anti-il-6 antibodies, compositions, methods and uses
08/04/16Anti-cd38 antibodies for treatment of acute myeloid leukemia
07/28/16Suspension culturing of pluripotent stem cells
07/07/16Anti-tissue factor antibodies and compositions
06/16/16Treatment of retinal degeneration using progenitor cells
06/09/16Treatment of ocular conditions using progenitor cells
06/09/16Differentiation of human pluripotent stem cells
03/24/16Non-natural consensus albumin binding domains
03/10/16Combination therapies with anti-cd38 antibodies
03/03/16Palm activated drug delivery device
02/11/16Fibronectin type iii domain based scaffold compositions, methods and uses
02/11/16Differentiation of pluripotent stem cells
02/11/16Fibronectin type iii repeat based protein scaffolds with alternative binding surfaces
02/04/16Cellular therapy for ocular degeneration
02/04/16Differentiation of human embryonic stem cells
01/14/16Human oncostatin m antibodies and methods of use
12/24/15Interferon alpha and omega antibody antagonists
12/10/15Differentiation of human embryonic stem cells into single hormonal insulin positive cells
11/26/15Antibody fc mutants with ablated effector functions
11/19/15Anti-il-23 antibodies, compositions, methods and uses
11/19/15Use of small molecules to enhance mafa expression in pancreatic endocrine cells
Patent Packs
10/29/15Anti-phf-tau antibodies and their uses
10/22/15Human anti-cd27 antibodies, methods and uses
10/15/15Methods and vectors for generating asialylated immunoglobulins
09/17/15Antibodies with improved half-life in ferrets
09/03/15Combination therapies with anti-cd38 antibodies
09/03/15Anti-cd38 antibodies for treatment of acute lymphoblastic leukemia
07/30/15Compositions and methods for phagocyte delivery of anti-staphylococcal agents
07/09/15Differentiation of human embryonic stem cells
07/02/15Biomarkers for anti-tnf treatment in ulcerative colitis and related disorders
06/18/15Pluripotent stem cell culture on micro-carriers
05/28/15Vectors, host cells, and methods of production and uses
05/21/15Active protease-resistant antibody fc mutants
05/07/15Anti-ccl17 antibodies
04/30/15Antibody fc mutants with ablated effector functions
04/16/15Cysteine engineered fibronectin type iii domain binding molecules
Patent Packs
04/09/15Protoxin -ii variants and methods of use
03/26/15Huwentoxin-iv variants and methods of use
03/26/15Human autotaxin antibodies and methods of use
01/29/15Method of treating crohn's disease by administering an anti-il-12 antibody
01/08/15Propylene glycol compositions for intranasal administration of active agents to the central nervous system
09/18/14Media suction devices and methods
09/18/14Interferon alpha and omega antibody antagonists
09/18/14Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recombinant proteins
09/11/14Kv1.3 antagonists and methods of use
09/11/14Bispecific egfr/c-met antibodies
08/28/14Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells
08/21/14Human tissue factor antibody and uses thereof
08/07/14Antibodies binding human collagen ii
07/31/14Methods of treating tnf-alpha-mediated diseases using chimeric tnf-alpha antibodies
07/31/14Toll-like receptor 3 antagonists
07/24/14Il4/il13 binding repeat proteins and uses
07/03/14Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
07/03/14Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators
06/26/14Method for treating psoriasis by administering an anti-il-12 antibody
06/12/14Anti-glp-1r antibodies and their uses
06/12/14Differentiation of human embryonic stem cells into pancreatic endoderm
06/05/14Egfr and c-met fibronectin type iii domain binding molecules
06/05/14Egfr and c-met fibronectin type iii domain binding molecules
05/22/14Bispecific egfr/c-met antibodies
05/22/14Anti-il-6 antibodies, compositions, methods and uses
05/22/14Pentraxin 3 association with asthma
05/22/14Vectors, host cells, and methods of production and uses
05/08/14Anti-il-23 antibodies, compositions, methods and uses
04/10/14Anti-il-6 antibodies, compositions, methods and uses
04/03/14Toll-like 3 receptor antagonists
Social Network Patent Pack
04/03/14Anti-integrin immunoconjugates, methods and uses
03/20/14Anti-cd147 antibodies, methods and uses
03/20/14Treatment of pluripotent cells
02/13/14Anti-il-23 antibodies, compositions, methods and uses
01/16/14Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
01/16/14Stabilized fibronectin domain compositions, methods and uses
01/09/14Markers and methods for assessing and treating crohn's disease and related disorders
01/09/14Serum markers for identification of cutaneous systemic sclerosis subjects
12/19/13St2l antagonists and methods of use
11/28/13Methods for predicting anti-integrin antibody response
Patent Packs
11/28/13Non-natural consensus albumin binding domains
11/21/13Huwentoxin-iv variants and methods of use
11/07/13Binding proteins having tethered light chains
10/31/13St2l antagonists and methods of use
10/24/13Toll-like receptor 3 antagonists
09/19/13Human anti-cd27 antibodies, methods and uses
09/19/13Toll-like receptor 3 antagonists
09/12/13Immunoglobulin cleavage fragments and disease indicators and compositions for detecting and binding such
09/12/13Defined media for expansion and maintenance of pluripotent stem cells
07/25/13Human tissue factor antibody and uses thereof
07/25/13Differentiation of human embryonic stem cells into single hormonal insulin positive cells
07/18/13Methods of treating hepatitis with anti-tnf alpha antibodies
07/04/13Methods of treating giant cell arteritis with anti-tnf alpha antibodies
05/23/13Method for treating psoriatic arthritis by administering an anti-il-12 antibody
04/11/13Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
03/28/13Fibronectin type iii repeat based protein scaffolds with alternative binding surfaces
03/14/13Method for treating crohn's disease by administering an anti-il-12 antibody
03/01/12Differentiation of human embryonic stem cells
03/01/12Differentiation of human embryonic stem cells
03/01/12Differentiation of pluripotent stem cells
02/16/12Treatment of diabetes with pancreatic endocrine precursor cells







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Janssen Biotech Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Janssen Biotech Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';